|
Spontaneous Initiative that Unites Scientists, Doctors, Lawyers and Free Citizens from All over the World
|
By Antonietta Gatti, Robert F. Kennedy Jr, and Luc Montagnier
Global Research, September 17, 2020
International Free Choice
|
Url of this article:
https://www.globalresearch.ca/initiative-unites-scientists-doctors-lawyers-free-citizens-world/5724155
|
|
The independent studies of various scientists have highlighted several issues on the virus. Many inconsistencies have emerged from many points of view which are summarized in these two letters. The reflections start from two complementary approaches and ask for explanations by offering new approaches and protocols.
***
Recipients
- Tedros Adhanom Ghebreyesus , World Health Organization;
- Mario Monti , Head of Health for the World Health Organization;
- Ursula Von der Leyen , President of the European Commission;
- David Sassoli, President of the European Parliament;
- to the Presidents of each Nation;
- to the Ministers of Health of each nation.
Letter from:
Antonietta Gatti, Fellow of Soc. Of Biomaterials and Eng., Italy
Robert F. Kennedy, Jr., Lawyer, USA
Dear Presidents and Ministers,
As an international group of scientists, doctors and lawyers, we contact you today about the SARS-CoV-2 pandemic, which has changed life around the world.
A variety of aspects about the SARS-CoV-2 virus and related therapeutics have been proven wrong. These included information provided by the WHO, the EU and governmental bodies in many European countries.
We are particularly concerned about the mechanism by which the virus works and the therapeutic protocols used almost identically around the world.
Several clinical aspects of SARS-CoV-2 behavior that we have observed are in stark contrast to what information authorities and the media have reported.
To properly understand the viral activity of SARS-CoV-2, we need more information.
A key question is why the concentration of lethality [% of deaths out of total positive subjects] was so different across European countries.
Therefore, we seek to understand and scientifically explain the concentration of mortality differences [the differences in mortality rates] from the virus in different countries and areas of Europe.
This knowledge is essential to determine if an ad hoc vaccine , with all the associated risks, is really necessary, as many of you have stated.
If there is no answer we will consider you in accordance with our conclusions.
We thank you for your attention, and confident of your feedback, we send you cordial greetings.
***
Luc Montagnier, Nobel Prize in Medicine, France
Dear Presidents and Ministers,
As an international group of scientists, doctors and lawyers, we reach out to you today regarding the SARS-CoV-2 epidemic, which has changed the lives of people around the world.
After a period of bewilderment in formulating both the diagnosis of covid-19 infection and the therapy for patients, it appears that, as with many other viral infections, there are three types of clinical features of this infection:
- asymptomatic in patients with positive PCR;
- symptomatic with mild clinical signs;
- symptomatic with severe organ failure.
A therapy experimented for the first time in China and developed in France by Pr Didier Raoult has shown to have some effectiveness in the first two groups of patients. This therapy involves the use of moderate-dose hydroxychloroquine in combination with azithromycin, immunomodulators and antioxidants, and aims to prevent these patients from evolving into the most severe phase three.
We propose that a therapeutic protocol based on clinical experience be developed by a medical commission. This committee should be independent of the economic pressure from pharmaceutical companies, political groups and editors of scientific journals.
It has been shown that the evolution of patients from phase 2 to phase 3 could be blocked by the above therapy. Consequently, lethality (ratio of deaths to PCR-positive patients) could be an important efficacy parameter of this protocol.
If there is no answer we will consider you in accordance with our conclusions.
Best regards
***
First signatories
Wolfgang Wodarg, Medical Doctor, Germany
Chinda Brandolino, Medical Doctor, Argentina
Maria José Albarracin, Medical Doctor, Spain
Reiner Füllmich, Laywer, Germany
Markus Haintz, Laywer, Germany
José Ortega, Laywer, Spain
Jean Pierre Eudier, Dr. Dentist Surgeon, Luxemburg
Luca Speciani, Medical Doctor, Italy
Tiziana Vigni, Lawyer, Italy
Wilhem Engel
Farmaceutical Sciences, Holland
Click here to sign the letters.
*
Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
|
|
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article.
|
|
|
|
